Suchergebnisse - "Tondini, Carlo"

PubPharm (13)

1

Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer : Analysis of four prospective studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Miglietta, F. | Dieci, M. | Giarratano, T. | +18

2

Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer : Final analysis of MetaPHER, a phase IIIb single-arm safety study

enthalten in: Breast cancer research and treatment | 2021

von Kuemmel, S. | Tondini, C. | Abraham, J. | +13

3

The use of genomic tests in patients with breast cancer in Lombardy : a successful healthcare model

enthalten in: Tumori | 2021

von Pruneri, G. | Tondini, C.

4

Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy : The BONDX study

enthalten in: Breast (Edinburgh, Scotland) | 2020

von Zambelli, A. | Simoncini, E. | Giordano, M. | +11

5

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women : Results From TEXT and SOFT

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Pagani, O. | Francis, P. | Fleming, G. | +13

6

Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer : extending endocrine sensitivity

enthalten in: Future oncology (London, England) | 2020

von Frassoldati, A. | Biganzoli, L. | Bordonaro, R. | +13

7

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial

enthalten in: Breast cancer research : BCR | 2019

von Rossi, L. | Biagioni, C. | McCartney, A. | +17

8

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2019

von Bachelot, T. | Ciruelos, E. | Schneeweiss, A. | +111

CommentIn: Ann Oncol. 2019 May 1;30(5):665-667. - PMID 30888412

9

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

enthalten in: The New England journal of medicine | 2018

von Francis, P. | Pagani, O. | Fleming, G. | +134

CommentIn: N Engl J Med. 2018 Jul 12;379(2):193-194. - PMID 29863436

10

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer : TEXT and SOFT Trials

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Regan, M. | Francis, P. | Pagani, O. | +12

CommentIn: J Clin Oncol. 2016 Jul 1;34(19):2203-5. - PMID 27185850